Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]

Nichols KK, Holland E, Toyos MM, et al. Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial. Clin Ophthalmol. 2018;12:263-270.On page 266, both mentions of Figure 3, should be Figure 4. On page 267, Figure 4 is drawn incorrectly.Read t...

Full description

Saved in:
Bibliographic Details
Published in:Clinical ophthalmology (Auckland, N.Z.) N.Z.), 2018-05, Vol.12, p.913-914
Main Authors: Nichols, Kelly, Holland, Edward, Toyos, Melissa M, Peace, James, Majmudar, Parag, Raychaudhuri, Aparna, Hamdani, Mohamed, Roy, Monica, Shojaei, Amir
Format: Article
Language:English
Subjects:
Corrigendum
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Nichols KK, Holland E, Toyos MM, et al. Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial. Clin Ophthalmol. 2018;12:263-270.On page 266, both mentions of Figure 3, should be Figure 4. On page 267, Figure 4 is drawn incorrectly.Read the original article.
ISSN:1177-5483
1177-5467
1177-5483
DOI:10.2147/OPTH.S168970